{
    "clinical_study": {
        "@rank": "46785", 
        "arm_group": {
            "arm_group_label": "LE Gel", 
            "arm_group_type": "Experimental", 
            "description": "A single dose LE Gel 0.5% administered into the study eye, tear samples collected at 6, 9, 12, and 24 hours after instillation by Schirmer strip to measures levels of LE in tears."
        }, 
        "brief_summary": {
            "textblock": "To assess the levels of loteprednol etabonate (LE) in tear fluid following a single topical\n      instillation of LE ophthalmic gel 0.5% formulation to healthy volunteers."
        }, 
        "brief_title": "Tear Fluid Levels of Loteprednol Etabonate Ophthalmic Gel 0.5% Following a Single Instillation", 
        "clinical_results": {
            "baseline": {
                "group_list": {
                    "group": {
                        "@group_id": "B1", 
                        "description": "A single dose LE Gel 0.5% administered into the study eye, tear samples collected at 6, 9, 12, and 24 hours after instillation by Schirmer strip to measures levels of LE in tears.\nLE Gel : Single drop of LE Gel 0.5% administered to the study eye on visit 2", 
                        "title": "LE Gel"
                    }
                }, 
                "measure_list": {
                    "measure": [
                        {
                            "category_list": {
                                "category": {
                                    "measurement_list": {
                                        "measurement": {
                                            "@group_id": "B1", 
                                            "@value": "12"
                                        }
                                    }
                                }
                            }, 
                            "param": "Number", 
                            "title": "Number of Participants", 
                            "units": "participants"
                        }, 
                        {
                            "category_list": {
                                "category": {
                                    "measurement_list": {
                                        "measurement": {
                                            "@group_id": "B1", 
                                            "@spread": "11.37", 
                                            "@value": "45.6"
                                        }
                                    }
                                }
                            }, 
                            "dispersion": "Standard Deviation", 
                            "param": "Mean", 
                            "title": "Age, Customized", 
                            "units": "years"
                        }, 
                        {
                            "category_list": {
                                "category": [
                                    {
                                        "measurement_list": {
                                            "measurement": {
                                                "@group_id": "B1", 
                                                "@value": "1"
                                            }
                                        }, 
                                        "sub_title": "Female"
                                    }, 
                                    {
                                        "measurement_list": {
                                            "measurement": {
                                                "@group_id": "B1", 
                                                "@value": "11"
                                            }
                                        }, 
                                        "sub_title": "Male"
                                    }
                                ]
                            }, 
                            "param": "Number", 
                            "title": "Gender", 
                            "units": "participants"
                        }, 
                        {
                            "category_list": {
                                "category": {
                                    "measurement_list": {
                                        "measurement": {
                                            "@group_id": "B1", 
                                            "@value": "12"
                                        }
                                    }, 
                                    "sub_title": "United States"
                                }
                            }, 
                            "param": "Number", 
                            "title": "Region of Enrollment", 
                            "units": "participants"
                        }
                    ]
                }
            }, 
            "certain_agreements": {
                "pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.", 
                "restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed."
            }, 
            "limitations_and_caveats": "All 12 subjects were exposed to a single dose of LE Gel.", 
            "outcome_list": {
                "outcome": [
                    {
                        "description": "Following a single dose of LE gel 0.5% administered into the study eye, tear samples will be collected via a Schirmer strip at 6, 9, 12 and 24 hours following the dose", 
                        "group_list": {
                            "group": {
                                "@group_id": "O1", 
                                "description": "A single dose LE Gel 0.5% administered into the study eye, tear samples collected at 6, 9, 12, and 24 hours after instillation by Schirmer strip to measures levels of LE in tears.\nLE Gel : Single drop of LE Gel 0.5% administered to the study eye on visit 2", 
                                "title": "LE Gel"
                            }
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@value": "12"
                                                }
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@spread": "116.0133", 
                                                    "@value": "113.633"
                                                }
                                            }
                                        }
                                    }, 
                                    "description": "Following a single dose of LE gel 0.5% administered into the study eye, tear samples will be collected via a Schirmer strip at 6, 9, 12 and 24 hours following the dose", 
                                    "dispersion": "Standard Deviation", 
                                    "param": "Mean", 
                                    "title": "Tear Fluid Levels", 
                                    "units": "\u03bcg/g"
                                }
                            ]
                        }, 
                        "population": "The primary analysis includes all subjects in the safety population with tear samples collected within the corresponding time window.", 
                        "safety_issue": "No", 
                        "time_frame": "6 hours", 
                        "title": "Tear Fluid Levels", 
                        "type": "Primary"
                    }, 
                    {
                        "description": "Following a single dose of LE gel 0.5% administered into the study eye, tear samples will be collected via a Schirmer strip at 6, 9, 12 and 24 hours following the dose", 
                        "group_list": {
                            "group": {
                                "@group_id": "O1", 
                                "description": "A single dose LE Gel 0.5% administered into the study eye, tear samples collected at 6, 9, 12, and 24 hours after instillation by Schirmer strip to measures levels of LE in tears.\nLE Gel : Single drop of LE Gel 0.5% administered to the study eye on visit 2", 
                                "title": "LE Gel"
                            }
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@value": "10"
                                                }
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@spread": "18.1625", 
                                                    "@value": "19.667"
                                                }
                                            }
                                        }
                                    }, 
                                    "description": "Following a single dose of LE gel 0.5% administered into the study eye, tear samples will be collected via a Schirmer strip at 6, 9, 12 and 24 hours following the dose", 
                                    "dispersion": "Standard Deviation", 
                                    "param": "Mean", 
                                    "title": "Tear Fluid Levels", 
                                    "units": "\u03bcg/g"
                                }
                            ]
                        }, 
                        "population": "The primary analysis includes all subjects in the safety population with tear samples collected within the corresponding time window.", 
                        "safety_issue": "No", 
                        "time_frame": "9 hours", 
                        "title": "Tear Fluid Levels", 
                        "type": "Primary"
                    }, 
                    {
                        "description": "Following a single dose of LE gel 0.5% administered into the study eye, tear samples will be collected via a Schirmer strip at 6, 9, 12 and 24 hours following the dose", 
                        "group_list": {
                            "group": {
                                "@group_id": "O1", 
                                "description": "A single dose LE Gel 0.5% administered into the study eye, tear samples collected at 6, 9, 12, and 24 hours after instillation by Schirmer strip to measures levels of LE in tears.\nLE Gel : Single drop of LE Gel 0.5% administered to the study eye on visit 2", 
                                "title": "LE Gel"
                            }
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@value": "12"
                                                }
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@spread": "29.6464", 
                                                    "@value": "26.877"
                                                }
                                            }
                                        }
                                    }, 
                                    "description": "Following a single dose of LE gel 0.5% administered into the study eye, tear samples will be collected via a Schirmer strip at 6, 9, 12 and 24 hours following the dose", 
                                    "dispersion": "Standard Deviation", 
                                    "param": "Mean", 
                                    "title": "Tear Fluid Levels", 
                                    "units": "\u03bcg/g"
                                }
                            ]
                        }, 
                        "population": "The primary analysis includes all subjects in the safety population with tear samples collected within the corresponding time window.", 
                        "safety_issue": "No", 
                        "time_frame": "12 hours", 
                        "title": "Tear Fluid Levels", 
                        "type": "Primary"
                    }, 
                    {
                        "description": "Following a single dose of LE gel 0.5% administered into the study eye, tear samples will be collected via a Schirmer strip at 6, 9, 12 and 24 hours following the dose", 
                        "group_list": {
                            "group": {
                                "@group_id": "O1", 
                                "description": "A single dose LE Gel 0.5% administered into the study eye, tear samples collected at 6, 9, 12, and 24 hours after instillation by Schirmer strip to measures levels of LE in tears.\nLE Gel : Single drop of LE Gel 0.5% administered to the study eye on visit 2", 
                                "title": "LE Gel"
                            }
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@value": "11"
                                                }
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@spread": "3.3631", 
                                                    "@value": "2.408"
                                                }
                                            }
                                        }
                                    }, 
                                    "description": "Following a single dose of LE gel 0.5% administered into the study eye, tear samples will be collected via a Schirmer strip at 6, 9, 12 and 24 hours following the dose", 
                                    "dispersion": "Standard Deviation", 
                                    "param": "Mean", 
                                    "title": "Tear Fluid Levels", 
                                    "units": "\u03bcg/g"
                                }
                            ]
                        }, 
                        "population": "The primary analysis includes all subjects in the safety population with tear samples collected within the corresponding time window.", 
                        "safety_issue": "No", 
                        "time_frame": "24 hours", 
                        "title": "Tear Fluid Levels", 
                        "type": "Primary"
                    }
                ]
            }, 
            "participant_flow": {
                "group_list": {
                    "group": {
                        "@group_id": "P1", 
                        "description": "A single dose LE Gel 0.5% administered into the study eye, tear samples collected at 6, 9, 12, and 24 hours after instillation by Schirmer strip to measures levels of LE in tears.\nLE Gel : Single drop of LE Gel 0.5% administered to the study eye on visit 2", 
                        "title": "LE Gel"
                    }
                }, 
                "period_list": {
                    "period": {
                        "milestone_list": {
                            "milestone": [
                                {
                                    "participants_list": {
                                        "participants": {
                                            "@count": "12", 
                                            "@group_id": "P1"
                                        }
                                    }, 
                                    "title": "STARTED"
                                }, 
                                {
                                    "participants_list": {
                                        "participants": {
                                            "@count": "12", 
                                            "@group_id": "P1"
                                        }
                                    }, 
                                    "title": "COMPLETED"
                                }, 
                                {
                                    "participants_list": {
                                        "participants": {
                                            "@count": "0", 
                                            "@group_id": "P1"
                                        }
                                    }, 
                                    "title": "NOT COMPLETED"
                                }
                            ]
                        }, 
                        "title": "Overall Study"
                    }
                }, 
                "pre_assignment_details": "A total of 17 participants were screened for this study. Of those screened, 12 participants were included to receive treatment; these subjects constituted the Safety population. No participants discontinued from the study.", 
                "recruitment_details": "Single center, open label, single dose study in healthy volunteers. First participant enrolled 01/08/2013, last participant exited: 01/18/2013."
            }, 
            "point_of_contact": {
                "email": "raphaele.siou-mermet@bausch.com", 
                "name_or_title": "Rapha\u00eble Siou-Mermet, MD, MS", 
                "organization": "Bausch & Lomb Incorporated", 
                "phone": "+33160871491"
            }, 
            "reported_events": {
                "desc": "All 12 subjects were exposed to a single dose of LE Gel.", 
                "group_list": {
                    "group": {
                        "@group_id": "E1", 
                        "description": "A single dose LE Gel 0.5% administered into the study eye, tear samples collected at 6, 9, 12, and 24 hours after instillation by Schirmer strip to measures levels of LE in tears.\nLE Gel : Single drop of LE Gel 0.5% administered to the study eye on visit 2", 
                        "title": "LE Gel"
                    }
                }, 
                "other_events": {
                    "category_list": {
                        "category": [
                            {
                                "event_list": {
                                    "event": {
                                        "counts": {
                                            "@group_id": "E1", 
                                            "@subjects_affected": "1", 
                                            "@subjects_at_risk": "12"
                                        }, 
                                        "sub_title": "Total, other adverse events"
                                    }
                                }, 
                                "title": "Total"
                            }, 
                            {
                                "event_list": {
                                    "event": {
                                        "counts": {
                                            "@events": "1", 
                                            "@group_id": "E1", 
                                            "@subjects_affected": "1", 
                                            "@subjects_at_risk": "12"
                                        }, 
                                        "description": "Non-Ocular Treatment-Emergent Adverse Events Population: Safety", 
                                        "sub_title": "Headache"
                                    }
                                }, 
                                "title": "Nervous system disorders"
                            }
                        ]
                    }, 
                    "default_assessment": "Systematic Assessment", 
                    "default_vocab": "MedDRA (12.0)", 
                    "frequency_threshold": "5"
                }, 
                "time_frame": "24 hours"
            }
        }, 
        "completion_date": {
            "#text": "April 2013", 
            "@type": "Actual"
        }, 
        "condition": "Pharmacokinetics", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Subjects must be healthy volunteers with physiologically normal anterior segments not\n             exhibiting clinically significant biomicroscopy findings.\n\n          -  Subjects must have a best-corrected visual acuity of 20/20 or better in each eye.\n\n          -  Subjects must have no active ocular disease or allergic conjunctivitis.\n\n          -  Subjects must have a Schirmer test (without anesthesia) of \u2265 10mm in 5 minutes.\n\n          -  Subjects must not be using any topical ocular medications or systemic medication\n             other than acetaminophen.\n\n          -  Male subjects or female subjects who are not of childbearing potential. Female\n             subjects are considered to not be of childbearing potential if they are\n             postmenopausal for at least 12 months or permanently sterilized (eg, tubal occlusion,\n             hysterectomy, bilateral salpingectomy)\n\n        Exclusion Criteria:\n\n          -  Subjects having an intraocular pressure less than 5 mmHg or greater than 22 mmHg or\n             any type of glaucoma.\n\n          -  Subjects with a history of ocular trauma, infection, or inflammation within the last\n             3 months.\n\n          -  Subjects having any contraindication to the use of, or known sensitivity or allergy\n             to, the study drug(s) or their components.\n\n          -  Subjects wearing contact lenses on the day of Visit 2 and/or Visit 3 of the study\n\n          -  Subjects having, at the Investigator's discretion, the presence of any significant\n             illness that could be expected to interfere with the study."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "12", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "November 27, 2012", 
        "firstreceived_results_date": "August 27, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01736527", 
            "org_study_id": "808"
        }, 
        "intervention": {
            "arm_group_label": "LE Gel", 
            "description": "Single drop of LE Gel 0.5% administered to the study eye on visit 2", 
            "intervention_name": "LE Gel", 
            "intervention_type": "Drug", 
            "other_name": "Lotemax"
        }, 
        "intervention_browse": {
            "mesh_term": "Loteprednol etabonate"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "No", 
        "lastchanged_date": "August 27, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Rochester", 
                    "country": "United States", 
                    "state": "New York", 
                    "zip": "14609"
                }, 
                "name": "Bausch & Lomb Research Clinic"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "1", 
        "official_title": "Tear Fluid Levels of Loteprednol Etabonate Ophthalmic Gel 0.5% at 6, 9, 12, and 24 Hours Following a Single Instillation in Healthy Volunteers", 
        "overall_official": [
            {
                "affiliation": "Bausch & Lomb Incorporated", 
                "last_name": "Jeffery Schafer, OD, MS", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Bausch & Lomb Incorporated", 
                "last_name": "Raphaele Siou Mermet, MD, MS", 
                "role": "Study Director"
            }
        ], 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 1", 
        "primary_completion_date": {
            "#text": "January 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": [
            {
                "description": "Following a single dose of LE gel 0.5% administered into the study eye, tear samples will be collected via a Schirmer strip at 6, 9, 12 and 24 hours following the dose", 
                "measure": "Tear Fluid Levels", 
                "safety_issue": "No", 
                "time_frame": "6 hours"
            }, 
            {
                "description": "Following a single dose of LE gel 0.5% administered into the study eye, tear samples will be collected via a Schirmer strip at 6, 9, 12 and 24 hours following the dose", 
                "measure": "Tear Fluid Levels", 
                "safety_issue": "No", 
                "time_frame": "9 hours"
            }, 
            {
                "description": "Following a single dose of LE gel 0.5% administered into the study eye, tear samples will be collected via a Schirmer strip at 6, 9, 12 and 24 hours following the dose", 
                "measure": "Tear Fluid Levels", 
                "safety_issue": "No", 
                "time_frame": "12 hours"
            }, 
            {
                "description": "Following a single dose of LE gel 0.5% administered into the study eye, tear samples will be collected via a Schirmer strip at 6, 9, 12 and 24 hours following the dose", 
                "measure": "Tear Fluid Levels", 
                "safety_issue": "No", 
                "time_frame": "24 hours"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01736527"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Bausch & Lomb Incorporated", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Bausch & Lomb Incorporated", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "January 2013", 
        "study_design": "Endpoint Classification: Pharmacokinetics Study, Intervention Model: Single Group Assignment, Masking: Open Label", 
        "study_type": "Interventional", 
        "verification_date": "August 2013"
    }
}